PM4Onco

Personalized medicine for oncology (PM⁴Onco) aims to support molecular tumor boards in finding the best available treatment options for oncological patients. To achieve this and to make informed treatment planning decisions, physicians and researchers require access to a large amounts of data. While the required data often scattered across various sources in different formats, the digitalization presents an opportunity to integrate, harmonize and use the required data. 

A total of 25 project partners from across Germany have joined the PM⁴Onco consortium, including 22 university medical centers, to collaboratively develop a viable and usable solution. PM⁴Onco aims to establish an infrastructure for the use and exchange of data from clinical and biomedical research.

The project consortium is led by Prof. Dr. Dr. Melanie Börries (University Medical Center Freiburg), Prof. Dr. Benedikt Brors (German Cancer Research Center, Heidelberg), and Prof. Dr. Oliver Kohlbacher (University of Tübingen). At the Frankfurt site, our institute is involved in four of the project’s work packages, in collaboration with the University Cancer Center (UCT, Director: Prof. Dr. Christian Brandts), the Institute of Medical Informatics (Director: Prof. Dr. Holger Storf), and the Dr. Senckenberg Institute of Pathology (Director: Prof. Dr. Peter Wild).